Efficacy of biphasic insulin aspart in patients with type 2 diabetes

BIAsp 30 BID can reduce PPG levelsto a greater extent than other common treatment regimens, including basal insulin OD. Using BIAsp 30, even once daily, may allow some patients to reach glycemic targets with a degree of convenience and tolerability that may not be achievable with other treatment regimens.